Views: 0 Author: Site Editor Publish Time: 2025-12-16 Origin: Site
Author: QIAOERNA Oral Care R&D Team
Published by: QIAOERNA Official Technical Department
Carbamide peroxide is widely used in whitening gels and strips, but it is generally unsuitable for toothpaste tablet formulations.
Brands exploring carbamide peroxide toothpaste tablets frequently encounter unexpected problems such as pouch swelling, internal gas formation, rapid loss of whitening activity, and regulatory limitations.
This article explains why carbamide peroxide fails in toothpaste tablet systems, based on formulation chemistry, accelerated stability behavior, packaging stress mechanisms, and global peroxide regulations.
This is a technical guidance article for oral-care formulators and OEM manufacturers, not a consumer whitening guide.
Carbamide peroxide is a urea–hydrogen peroxide adduct. When exposed to moisture in the oral environment, it decomposes into:
*Hydrogen peroxide (H₂O₂) — the active whitening agent
*Urea — moderates peroxide release
The whitening mechanism is well established:
*Reactive oxygen species diffuse into enamel and dentin
*Chromogenic molecules are oxidized and fragmented
*Large pigments break down into smaller, less visible molecules
*Teeth appear brighter due to optical and surface changes
While this mechanism functions effectively in gels and strips, the same chemistry behaves very differently in solid, low-moisture toothpaste tablet systems.
Carbamide peroxide is commonly used in:
*At-home bleaching gels
*Whitening strips
*Whitening pens and overnight serums
*Professional dental whitening kits
These formats share several key characteristics:
*Water-based or semi-liquid systems
*Short-term, controlled exposure
*Higher regulatory oversight than daily-use toothpaste
These factors help manage hydrogen peroxide stability, dosage accuracy, and user safety, which cannot be easily replicated in toothpaste tablets intended for daily use.
Toothpaste tablets are low-water or waterless solid oral-care systems, designed for sustainability, portability, and dose control.
However, these same properties introduce formulation challenges when peroxide compounds are involved:
*Trace moisture in excipients can initiate peroxide decomposition
*Tablets absorb humidity during compression and storage
*Packaging films allow gradual moisture ingress over time
As a result, carbamide peroxide tablets are inherently less stable than liquid or gel whitening systems, even when high-barrier packaging is used.
One of the most common failures observed during development trials is sealed-package swelling, caused by peroxide decomposition inside the tablet.
Step 1 — Peroxide breakdown
Carbamide peroxide → hydrogen peroxide → water + oxygen gas
This reaction is accelerated by:
*Elevated temperature
*Residual or absorbed moisture
*pH shifts or trace catalytic ions
Step 2 — Tablets are never completely water-free
*Excipients contain inherent moisture
*Tablets absorb humidity during processing
*Packaging allows slow vapor diffusion over time
Step 3 — Gas accumulation inside sealed packaging
*Oxygen accumulates within pouches
*Pouches deform or inflate
*Risk of leakage, rupture, and loss of consumer confidence increases
In accelerated stability testing (40 °C / 75 % RH), gas formation and pouch deformation typically appeared within 4–8 weeks, even under high-barrier packaging conditions.
Hydrogen peroxide and peroxide-releasing compounds are strictly regulated worldwide.
*≤ 0.1 % hydrogen peroxide: permitted in cosmetic products
*0.1 %–6 %: restricted to dental supervision
*Typical 10 % carbamide peroxide gels cannot be sold as cosmetics
*Low levels allowed in OTC products
*Higher concentrations regulated as dental devices
*Many markets align closely with EU regulatory principles
These regulations significantly limit the practical whitening efficacy of carbamide peroxide in daily-use toothpaste tablet products.
Short answer: technically possible, but practically unsuitable.
To achieve compliance and stability, a peroxide-based toothpaste tablet would require:
*Extremely low peroxide concentrations
*High-barrier, moisture-controlled packaging
*Long-term validation of gas formation and pouch integrity
These requirements resemble professional whitening devices, not everyday toothpaste products designed for daily oral care.
From a formulation and regulatory perspective, carbamide peroxide is incompatible with toothpaste tablet systems due to:
*Predictable oxygen generation and pouch swelling
*Sensitivity to heat and humidity during transportation
*Regulatory incompatibility with daily oral-care classification
*Progressive loss of active oxygen over time
*Tablet softening under ambient storage conditions
As a result, peroxide-free whitening pathways are becoming the preferred solution for solid oral-care formats.
Hydroxyapatite (HAp)
*Enzymatic stain-degradation systems
*Silica-based mild polishing
*Optical brightening without peroxide
For a deeper technical comparison, see:
https://www.qiaoernatooth.com/Why-the-Next-Decade-of-Oral-Care-Belongs-to-Hydroxyapatite-Toothpaste-Tablets-id44557675.html
Do toothpaste tablets need peroxide to whiten?
No. Whitening can be achieved through mechanical cleaning and non-peroxide systems.
Why does pouch swelling occur?
Oxygen gas accumulates as peroxide decomposes inside sealed packaging.
Why does QIAOERNA avoid peroxide-based toothpaste tablets?
To ensure long-term stability, regulatory compliance, and safe daily use.
Can carbamide peroxide be added to toothpaste tablets?
Chemically yes, but it fails most long-term stability and packaging tests.
Can packaging fully prevent tablet failure?
Packaging may slow moisture ingress but cannot prevent internal gas formation.
This technical article was prepared and reviewed by the QIAOERNA Oral Care R&D Team, with expertise in toothpaste tablets, anhydrous oral-care systems, and long-term formulation stability testing.
PubMed Central — Peroxide safety and sensitivity research
EU Public Health — Hydrogen peroxide concentration regulations
CosmeticsDesign-Europe — Whitening product classification
Dental formulation literature on carbamide peroxide equivalence

